Effects of Exercise Training and DPP-4 Inhibitors on Cardiovascular Function in Type 2 Diabetic Patients with Myocardial Infarction.

Effects of Exercise Training and DPP-4 Inhibitors on Cardiovascular Function in Type 2 Diabetic Patients with Myocardial Infarction. - Exercise and DPP-4 Inhibitors in Type 2 Diabetics with Myocardial Infarction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014621

Enrollment

Registered

2014-07-24

Start date

2014-07-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetic patients with myocardial infraction

Interventions

Exercsei tarining and DPP-4 inhibitors(linagliptin) Exercse training alone DPP-4 inhibitors (linagliptin) alone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetic patients undergoing primary percutaneous coronary intervention for myocardial infarction.

Exclusion criteria

Exclusion criteria: Type 1 diabetics, residual coronary stenosis, severe valvular disease, renal failure, NYHA class 4 heart failure, atrial fibrillation, hypertrophic cardiomyopathy, therapies with insulin, glinides, previous cardiac rehabilitation, and pacemakers.

Design outcomes

Primary

Measure	Time frame
Exercise capacity	—

Countries

Japan

Contacts

Public ContactNaoto Kumagai

Mie University Graduate School of Medicine Department of Cardiology and Nephrology

kumagain@clin.medic.mie-u.ac.jp059-231-5015

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026